Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Serum High-Sensitivity C-Reactive Protein Levels and Response to 5 mg Tadalafil Once Daily in Patients With Erectile Dysfunction and Diabetes.

Lee JW, Park HJ, Park NC.

Korean J Urol. 2013 Dec;54(12):858-64. doi: 10.4111/kju.2013.54.12.858. Epub 2013 Dec 10.

2.

Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.

Porst H, Gacci M, Büttner H, Henneges C, Boess F.

Eur Urol. 2014 Feb;65(2):455-64. doi: 10.1016/j.eururo.2013.09.037. Epub 2013 Oct 2.

PMID:
24119319
3.

Impact of low testosterone on response to treatment with tadalafil 5 mg once daily for erectile dysfunction.

Goldfischer ER, Kim ED, Seftel AD, Baygani SK, Burns PR.

Urology. 2014 Jun;83(6):1326-33. doi: 10.1016/j.urology.2014.02.019. Epub 2014 Apr 13.

PMID:
24726311
4.

Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction.

Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G, Rose L, Lording D, Liang S.

Diabet Med. 2008 Feb;25(2):138-46. doi: 10.1111/j.1464-5491.2007.02338.x.

PMID:
18290855
6.

The correlation between high sensitivity C-reactive protein and erectile dysfunction patients with hypertension treated with vardenafil.

Azab S, Aoud H, Nabil N.

Int J Impot Res. 2017 Mar;29(2):82-85. doi: 10.1038/ijir.2016.51. Epub 2016 Dec 1.

PMID:
27904146
7.

Effect of once-daily tadalafil on confidence and perceived difficulty in performing sexual intercourse in men who were incomplete responders to as-needed PDE5 inhibitor treatment.

Seftel AD, Rosen RC, Hayes RP, Althof S, Goldfisher E, Shen W, Sontag A.

Int J Clin Pract. 2014 Jul;68(7):841-9. doi: 10.1111/ijcp.12406. Epub 2014 Mar 25.

PMID:
24666765
8.

Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.

Goldstein I, Kim E, Steers WD, Pryor JL, Wilde DW, Natanegara F, Wong DG, Ahuja S.

J Sex Med. 2007 Jan;4(1):166-75. Erratum in: J Sex Med. 2007 Mar;4(2):522.

PMID:
17233782
9.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S.

J Sex Med. 2006 Jul;3(4):668-75.

PMID:
16839323
11.

Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).

Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, Chevallier D, Krajka K, Henneges C, Dickson R, Büttner H.

Eur Urol. 2014 Mar;65(3):587-96. doi: 10.1016/j.eururo.2013.09.051. Epub 2013 Oct 13.

PMID:
24169081
12.

Effects of tadalafil on erectile dysfunction in men with diabetes.

Sáenz de Tejada I, Anglin G, Knight JR, Emmick JT.

Diabetes Care. 2002 Dec;25(12):2159-64.

PMID:
12453954
13.

A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.

Kim ED, Seftel AD, Goldfischer ER, Ni X, Burns PR.

J Sex Med. 2014 Mar;11(3):820-30. doi: 10.1111/jsm.12253. Epub 2013 Jul 10.

PMID:
23841532
14.

Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.

Sharlip ID, Shumaker BP, Hakim LS, Goldfischer E, Natanegara F, Wong DG.

J Sex Med. 2008 Mar;5(3):716-25. doi: 10.1111/j.1743-6109.2007.00712.x.

PMID:
18304286
15.

Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.

Shabsigh R, Seftel AD, Kim ED, Ni X, Burns PR.

J Sex Med. 2013 Mar;10(3):844-56. doi: 10.1111/j.1743-6109.2012.02898.x. Epub 2012 Oct 4.

PMID:
23035781
16.

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.

Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V.

Eur Urol. 2004 Sep;46(3):362-9; discussion 369.

PMID:
15306109
17.

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.

Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A.

BJU Int. 2004 Oct;94(6):871-7.

18.

Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.

Fonseca V, Seftel A, Denne J, Fredlund P.

Diabetologia. 2004 Nov;47(11):1914-23. Epub 2004 Nov 25.

PMID:
15599697
19.

Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.

Kim E, Seftel A, Goldfischer E, Baygani S, Burns P.

Curr Med Res Opin. 2015 Feb;31(2):379-89. doi: 10.1185/03007995.2014.989317. Epub 2014 Dec 2.

PMID:
25455432
20.

Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus.

Hamidi Madani A, Asadolahzade A, Mokhtari G, Shahrokhi Damavand R, Farzan A, Esmaeili S.

J Sex Med. 2013 Apr;10(4):1146-50. doi: 10.1111/jsm.12047. Epub 2013 Jan 24.

PMID:
23347176

Supplemental Content

Support Center